Gambichler, T.; Weyer-Fahlbusch, S.S.; Overbeck, J.; Abu Rached, N.; Becker, J.C.; Susok, L.
Impaired Overall Survival of Melanoma Patients Due to Antibiotic Use Prior to Immune Checkpoint Inhibitor Therapy: Systematic Review and Meta-Analysis. Cancers 2025, 17, 1872.
https://doi.org/10.3390/cancers17111872
AMA Style
Gambichler T, Weyer-Fahlbusch SS, Overbeck J, Abu Rached N, Becker JC, Susok L.
Impaired Overall Survival of Melanoma Patients Due to Antibiotic Use Prior to Immune Checkpoint Inhibitor Therapy: Systematic Review and Meta-Analysis. Cancers. 2025; 17(11):1872.
https://doi.org/10.3390/cancers17111872
Chicago/Turabian Style
Gambichler, Thilo, Sera S. Weyer-Fahlbusch, Jan Overbeck, Nessr Abu Rached, Jürgen C. Becker, and Laura Susok.
2025. "Impaired Overall Survival of Melanoma Patients Due to Antibiotic Use Prior to Immune Checkpoint Inhibitor Therapy: Systematic Review and Meta-Analysis" Cancers 17, no. 11: 1872.
https://doi.org/10.3390/cancers17111872
APA Style
Gambichler, T., Weyer-Fahlbusch, S. S., Overbeck, J., Abu Rached, N., Becker, J. C., & Susok, L.
(2025). Impaired Overall Survival of Melanoma Patients Due to Antibiotic Use Prior to Immune Checkpoint Inhibitor Therapy: Systematic Review and Meta-Analysis. Cancers, 17(11), 1872.
https://doi.org/10.3390/cancers17111872
